PARLAR-02 Trial:Modified Transanal Drainage Tube Use for Preventing Anastomotic Leakage
NCT: NCT07036588 · RECRUITING
Brief Summary
Surgical resection remains the primary treatment for rectal cancer, but the postoperative incidence of anastomotic leakage (AL) is relatively high. AL not only increases the medical burden on patients, prolongs hospital stays, raises the need for secondary surgery, and elevates perioperative mortality, but also increases the long-term risk of local recurrence and reduces survival rates. There is an urgent need for a simple, effective treatment method that minimizes the burden on patients to prevent anastomotic leakage. The preoperative placement of a transanal drainage tube (TDT) is believed to effectively drain gas and feces from the intestinal lumen, thereby reducing intestinal pressure and alleviating tension at the anastomotic site, thus preventing AL. Previous studies have shown that traditional drainage tubes cannot effectively prevent leakage. Given the limitations of existing research on traditional TDTs, we plan to use a modified TDT (which allows postoperative irrigation and utilizes a balloon to block feces from adversely affecting the anastomosis) to conduct a randomized, parallel-controlled trial. This study aims to further investigate the role of the modified TDT in preventing and treating anastomotic leakage following rectal surgery
Frequently Asked Questions
What is PARLAR-02 Trial:Modified Transanal Drainage Tube Use for Preventing Anastomotic Leakage?
PARLAR-02 Trial:Modified Transanal Drainage Tube Use for Preventing Anastomotic Leakage is a clinical trial registered under NCT07036588. Current status: RECRUITING.
What is the status of NCT07036588?
The current status of NCT07036588 (PARLAR-02 Trial:Modified Transanal Drainage Tube Use for Preventing Anastomotic Leakage) is: RECRUITING.
When did PARLAR-02 Trial:Modified Transanal Drainage Tube Use for Preventing Anastomotic Leakage start?
PARLAR-02 Trial:Modified Transanal Drainage Tube Use for Preventing Anastomotic Leakage started on 2025-07-07.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.